Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuting Wu

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
BMC Cancer|December 9, 2023
Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinomaShuting Wu, Xiaofei Yuan, Haoran Huang, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Specialized outputs and behavioral contributions of Purkinje cell subtypesShuting Wu, Chih-Chun Lin, Joon-Hyuk Lee, et al.
Journal of Cancer|April 15, 2021
Integrating pre- and post-treatment Plasma Epstein-Barr Virus DNA levels for better prognostic prediction of Nasopharyngeal CarcinomaWanxia Li, Chao Yang, Zehong Lv, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|July 7, 2019
Nlrc3-like is required for microglia maintenance in zebrafishTienan Wang, Bo Yan, Liang Lou, et al.
Frontiers in Oncology|August 12, 2025
Insights into the role of MSLN-positive circulating tumor cell as an auxiliary diagnostic biomarker in epithelial ovarian cancerHang Xu, Min Wang, Shuting Wu, et al.
Biomaterials|January 30, 2025
Bioinspired nanofiber dressings with counter-transport of exudate and drug for treating heavily exuding woundsXuening Jin, Yihao Wu, Zizhao Chen, et al.
BMC Cancer|November 25, 2023
Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinomaLinchong Cui, Zilu Chen, Fangfang Zeng, et al.
Diabetes, Obesity & Metabolism|April 20, 2026
A Phase 1, Randomised, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN069 (a Dual GLP-1R Agonist and GIPR Antagonist) in Male Adults With Overweight or ObesityJinlian Xie, Jie Huang, Qian Wu, et al.
Immunologic Research|February 15, 2022
Identification of nafamostat mesylate as a selective stimulator of NK cell IFN-γ production via metabolism-related compound library screeningQinglan Yang, Shuju Zhang, Shuting Wu, et al.
Journal of Cancer Research and Clinical Oncology|January 3, 2023
Systemic immune-inflammation index during treatment predicts prognosis and guides clinical treatment in patients with nasopharyngeal carcinomaXiaofei Yuan, Huiru Feng, Haoran Huang, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
BMC Cancer|December 9, 2023
Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinomaShuting Wu, Xiaofei Yuan, Haoran Huang, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Specialized outputs and behavioral contributions of Purkinje cell subtypesShuting Wu, Chih-Chun Lin, Joon-Hyuk Lee, et al.
Journal of Cancer|April 15, 2021
Integrating pre- and post-treatment Plasma Epstein-Barr Virus DNA levels for better prognostic prediction of Nasopharyngeal CarcinomaWanxia Li, Chao Yang, Zehong Lv, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|July 7, 2019
Nlrc3-like is required for microglia maintenance in zebrafishTienan Wang, Bo Yan, Liang Lou, et al.
Frontiers in Oncology|August 12, 2025
Insights into the role of MSLN-positive circulating tumor cell as an auxiliary diagnostic biomarker in epithelial ovarian cancerHang Xu, Min Wang, Shuting Wu, et al.
Biomaterials|January 30, 2025
Bioinspired nanofiber dressings with counter-transport of exudate and drug for treating heavily exuding woundsXuening Jin, Yihao Wu, Zizhao Chen, et al.
BMC Cancer|November 25, 2023
Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinomaLinchong Cui, Zilu Chen, Fangfang Zeng, et al.
Diabetes, Obesity & Metabolism|April 20, 2026
A Phase 1, Randomised, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN069 (a Dual GLP-1R Agonist and GIPR Antagonist) in Male Adults With Overweight or ObesityJinlian Xie, Jie Huang, Qian Wu, et al.
Immunologic Research|February 15, 2022
Identification of nafamostat mesylate as a selective stimulator of NK cell IFN-γ production via metabolism-related compound library screeningQinglan Yang, Shuju Zhang, Shuting Wu, et al.
Journal of Cancer Research and Clinical Oncology|January 3, 2023
Systemic immune-inflammation index during treatment predicts prognosis and guides clinical treatment in patients with nasopharyngeal carcinomaXiaofei Yuan, Huiru Feng, Haoran Huang, et al.
Pageof 10